Literature DB >> 21206509

Uncapping NF-κB activity in pancreatic cancer.

Sushma Gurumurthy1, Nabeel Bardeesy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21206509      PMCID： PMC3020124          DOI： 10.1038/emboj.2010.324

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  11 in total

Review 1.  Pancreatic cancer: molecular pathogenesis and new therapeutic targets.

Authors:  Han H Wong; Nicholas R Lemoine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06-09       Impact factor: 46.802

2.  An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Kevin Struhl
Journal:  Cell       Date:  2009-10-29       Impact factor: 41.582

3.  Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene.

Authors:  Xuesheng Feng; Zhong Guo; Mahtab Nourbakhsh; Hansjorg Hauser; Ray Ganster; Lifang Shao; David A Geller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

4.  miR-301a as an NF-κB activator in pancreatic cancer cells.

Authors:  Zhongxin Lu; Yan Li; Apana Takwi; Benhui Li; Jingwen Zhang; Daniel J Conklin; Ken H Young; Robert Martin; Yong Li
Journal:  EMBO J       Date:  2010-11-26       Impact factor: 11.598

5.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

Authors:  Pedro P Medina; Mona Nolde; Frank J Slack
Journal:  Nature       Date:  2010-08-08       Impact factor: 49.962

6.  Dicer1 functions as a haploinsufficient tumor suppressor.

Authors:  Madhu S Kumar; Ryan E Pester; Cindy Y Chen; Keara Lane; Christine Chin; Jun Lu; David G Kirsch; Todd R Golub; Tyler Jacks
Journal:  Genes Dev       Date:  2009-11-10       Impact factor: 11.361

Review 7.  NF-kappaB as a critical link between inflammation and cancer.

Authors:  Michael Karin
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11       Impact factor: 10.005

8.  Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma.

Authors:  Etienne Meylan; Alison L Dooley; David M Feldser; Lynn Shen; Erin Turk; Chensi Ouyang; Tyler Jacks
Journal:  Nature       Date:  2009-10-21       Impact factor: 49.962

9.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.

Authors:  David A Barbie; Pablo Tamayo; Jesse S Boehm; So Young Kim; Susan E Moody; Ian F Dunn; Anna C Schinzel; Peter Sandy; Etienne Meylan; Claudia Scholl; Stefan Fröhling; Edmond M Chan; Martin L Sos; Kathrin Michel; Craig Mermel; Serena J Silver; Barbara A Weir; Jan H Reiling; Qing Sheng; Piyush B Gupta; Raymond C Wadlow; Hanh Le; Sebastian Hoersch; Ben S Wittner; Sridhar Ramaswamy; David M Livingston; David M Sabatini; Matthew Meyerson; Roman K Thomas; Eric S Lander; Jill P Mesirov; David E Root; D Gary Gilliland; Tyler Jacks; William C Hahn
Journal:  Nature       Date:  2009-10-21       Impact factor: 49.962

10.  Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.

Authors:  Andrea Ventura; Amanda G Young; Monte M Winslow; Laura Lintault; Alex Meissner; Stefan J Erkeland; Jamie Newman; Roderick T Bronson; Denise Crowley; James R Stone; Rudolf Jaenisch; Phillip A Sharp; Tyler Jacks
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582
View more
  3 in total

1.  Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1.

Authors:  Daniela Basso; Dania Bozzato; Andrea Padoan; Stefania Moz; Carlo-Federico Zambon; Paola Fogar; Eliana Greco; Michele Scorzeto; Francesca Simonato; Filippo Navaglia; Matteo Fassan; Michela Pelloso; Sirio Dupont; Sergio Pedrazzoli; Ambrogio Fassina; Mario Plebani
Journal:  Cell Commun Signal       Date:  2014-03-26       Impact factor: 5.712

Review 2.  The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance.

Authors:  Sunjida Ahmed; Azore-Dee Bradshaw; Shweta Gera; M Zahidunnabi Dewan; Ruliang Xu
Journal:  J Clin Med       Date:  2017-01-05       Impact factor: 4.241

3.  Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.

Authors:  Ruiyu Li; Yangzhige He; Hui Zhang; Jing Wang; Xiaoding Liu; Hangqi Liu; Huanwen Wu; Zhiyong Liang
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.